Alzheimer’s Disease Diagnostic Market Size, Trends and Insights by Type (Early-onset Alzheimer’s, Late-onset Alzheimer’s, Familial Alzheimer’s disease), Diagnostic test (Genetic testing, Neurological exam, Mini-mental state exam (MMSE), Brain imaging), End Users (Clinics, Hospitals, Diagnostic Centers) – Forecast Till 2030
Alzheimers Disease Diagnostic Market is expected to reach USD 7,100 Million by 2030 at 8.90% CAGR during the forecast period 2022-2030. Alzheimer’s disease is a common disorder in the ageing population. Alzheimer’s Disease Diagnostic Market is progressing due to using biomarkers for diagnosis and drug development.
The Alzheimer’s disease diagnostic market refers to the market for products and services used in the diagnosis of Alzheimer’s disease. This includes various tests, tools, and technologies used to detect the presence of Alzheimer’s disease in patients. The market includes both in vitro diagnostics (IVD) and imaging technologies; there is a growing demand for accurate and reliable diagnostic tools for Alzheimer’s disease.
Get Free Sample PDF Brochure @ https://www.marketresearchfuture.com/sample_request/2149
The COVID-19 pandemic has had a significant impact on the Alzheimer’s disease diagnostic market. In COVID-19 pandemic, many patients with Alzheimer’s disease or other cognitive disorders have experienced delayed or reduced access to diagnostic testing. This has led to a reduction in demand for diagnostic tests for Alzheimer’s disease.
The economic impact of the pandemic has led to a reduction in funding for research and development, including in the area of Alzheimer’s disease diagnosis. This has hindered the development of new diagnostic tools and technologies.
Alzheimer’s Disease Diagnostic Market Segmentation
The alzheimer’s disease diagnostic market has been segmented into type, diagnostic test and end-user.
Based on the type, the market has been segmented into Early-onset, Late-onset and Familial Alzheimer’s disease.
Based on the diagnostic test, the market has been segmented into Genetic testing, Neurological exam, Mini-mental state exam and Brain imaging.
Based on the end-user, the market has been segmented into Clinics, Hospitals and Diagnostic Centers.
Alzheimer’s Disease Diagnostic Market Key Players
Some of the key market players are:
- Eli Lilly and Company (UK)
- TauRx (Republic of Singapore)
- Alector LLC (US)
- Accera Inc. (US)
- Treventis Corporation (US)
- Neuro-Bio Ltd (UK)
- Cognition Therapeutics Inc. (US)
Alzheimer’s Disease Diagnostic Market Regional Analysis
North America is the largest region for the Alzheimer’s disease diagnostic market. This is due to several factors such as the high prevalence of Alzheimer’s disease in the region, the presence of a well-established healthcare infrastructure, and a strong focus on research and development in the area of Alzheimer’s disease diagnosis.
Browse In-depth Market Research Report (88 Pages) on Alzheimer’s Disease Diagnostic: https://www.marketresearchfuture.com/reports/alzheimers-disease-diagnostic-market-2149
North America dominated the Alzheimer’s disease diagnostic market in 2020, accounting for a share of over 40% of the global market. The report attributes this dominance to the high awareness levels about the disease, the presence of leading diagnostic and pharmaceutical companies in the region.
Browse Related Reports at
Genetic Testing Market Size amd Trends Analysis By Type (Prescribed Genetic Testing and Direct-to-Consumer Genetic Testing), Method (Molecular Genetic Tests/ DNA Tests, Chromosomal Genetic Tests and Biochemical Genetic Tests), By Application (Reproductive Health (Newborn Screening, Prenatal Screening and Carrier Screening), Cancer Screening (Hereditary Cancer, Breast Cancer, Ovarian Cancer and Colon Cancer), Ancestry, Predictive and Pre-Symptomatic Testing and others) – Forecast till 2030
Neurology Devices Market Trends, Growth and Size Analysis By Product (Neurostimulation, Interventional Neurology, CSF Management, Neurosurgery Devices), End User (Hospitals & Clinics, Specialty Center) and Region (Americas, Europe, Asia-Pacific, Middle East & Africa) – Forecast to 2030
Brain Monitoring Devices Market Information, by Application (Stroke, Headache Disorders, Epilepsy, Parkinson & rsquo;s Disease), By Type (X Rays, MRI Systems, CT), By End Users (Hospital & Clinical, Research Laboratories, and Academic Institutes), by Region – Forecast to 2030
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Contact:
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5Th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)
Email: sales@marketresearchfuture.com
Website: https://www.marketresearchfuture.com